Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/49971
Title: Salicylate decreases production of AmpC type β-lactamases and increases susceptibility to β-lactams in a Morganella morganii clinical isolate
Authors: Tavío, María M. 
Perilli, Mariagrazia
Vila, Jordi
Becerro, Pino
Casañas, Lucía
Amicosante, Gianfranco
Teresa Jiménez De Anta, María
Keywords: Multiple Antibiotic-Resistance
Enterobacter-Cloacae
Escherichia-Coli
Outer-Membrane
Expression, et al
Issue Date: 2004
Publisher: 0378-1097
Journal: FEMS Microbiology Letters 
Abstract: The effect of salicylate, a marRAB inducer, on the resistance to beta-lactams was characterized in an AmpC beta-lactamase hyperproducer Morganella morganii clinical isolate (the M1 strain). Results were compared with those of the effect of salicylate in a wild-type M. morganii strain. Salicylate induced a decreased susceptibility to nalidixic acid, norfloxacin and tetracycline and simultaneously increased the susceptibility to beta-lactams apparently due to the repression of AmpC P-lactamase synthesis in the M1 strain. Likewise, salicylate only repressed 46 kDa outer membrane protein expression in the wild-type strain, since the clinical isolate M1 did not express it. (C) 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
URI: http://hdl.handle.net/10553/49971
ISSN: 0378-1097
DOI: 10.1016/j.femsle.2004.07.030
Source: FEMS Microbiology Letters[ISSN 0378-1097],v. 238, p. 139-144
Appears in Collections:Artículos
Show full item record

SCOPUSTM   
Citations

4
checked on May 9, 2021

WEB OF SCIENCETM
Citations

4
checked on May 9, 2021

Page view(s)

11
checked on May 10, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.